2023-11-01 12:08:13 ET
DENVER, Colo., Nov. 1, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Aldeyra Therapeutics Inc (NASDAQ: ALDX), Cellectis SA (NASDAQ: CLLS), TG Therapeutics, Inc. (NASDAQ: TGTX), Monopar Therapeutics Inc. (NASDAQ: MNPR), MSP Recovery Inc (NASDAQ: LIFW), and BioXcel Therapeutics Inc (NASDAQ: BTAI).
News
Aldeyra Therapeutics Enters into Exclusive Option Agreement with AbbVie for License to Develop and Commercialize Reproxalap- Aldeyra Therapeutics Inc (NASDAQ: ALDX) is trading at $2.08, up $0.37 (+21.73%), on 4.68M shares traded.
Cellectis Announces Strategic Collaboration and Investment Agreements with AstraZeneca- Cellectis SA (NASDAQ: CLLS) is trading at $2.37, up $1.41 (+145.86%), up 38.99M shares traded.
TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results- …
The post 24/7 Market News Lunch Break 1 Nov 2023 appeared first on 24/7 Market News .
For further details see:
24/7 Market News Lunch Break 1 Nov 2023